Litcius/Paper detail

Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study

Do-Youn Oh, Kyung-Hun Lee, Dae-Won Lee, Jeesun Yoon, Tae-Yong Kim, Ju-Hee Bang, Ah-Rong Nam, Kyoung-Seok Oh, Jae-Min Kim, Young Lee, Violeta Guthrie, Patricia McCoon, Weimin Li, Song Wu, Qu Zhang, Marlon C Rebelatto, Jin Won Kim

2022˜The œLancet. Gastroenterology & hepatology315 citationsDOI

Topics & Concepts

DurvalumabTremelimumabMedicineGemcitabineCisplatinInternal medicineOncologyBiliary tract cancerPhases of clinical researchBiliary tractChemotherapyPhase (matter)CancerImmune systemClinical trialCancer researchChemoradiotherapyRespiratory tractCholangiocarcinoma and Gallbladder Cancer StudiesLiver Diseases and ImmunityGallbladder and Bile Duct Disorders